New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties

BACKGROUND: Viloxazine was historically described as a norepinephrine reuptake inhibitor (NRI). Since NRIs have previously demonstrated efficacy in attention deficit/hyperactivity disorder (ADHD), viloxazine underwent contemporary investigation in the treatment of ADHD. Its clinical and safety profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chungping, Garcia-Olivares, Jennie, Candler, Shawn, Schwabe, Stefan, Maletic, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473988/
https://www.ncbi.nlm.nih.gov/pubmed/32943948
http://dx.doi.org/10.2147/JEP.S256586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473988/
https://www.ncbi.nlm.nih.gov/pubmed/32943948
http://dx.doi.org/10.2147/JEP.S256586

Ejemplares similares